<DOC>
	<DOCNO>NCT01672996</DOCNO>
	<brief_summary>To optimize Ioforminol concentration dosage ( ) CECT abdomen . To evaluate safety tolerability low concentration Ioforminol Injections . Study recruit healthy volunteer .</brief_summary>
	<brief_title>Open Label , Randomized Study Low Concentration Ioforminol Injections Use Abdominal CECT Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male females 18 50 year age . The subject maximum abdominal circumference 120 cm less . The subject know Grade 3 4 allergic reaction/hypersensitivity either iodine iodinatedbased contrast agent history multiple allergy ( i.e. , food , pet , medication , etc ) . The subject chronic renal insufficiency ( estimate glomerular filtration rate [ eGFR ] &lt; 60 mg/dL ) measure screen visit . The subject pregnant breastfeeding . The subject suspicion diagnosis hyperthyroidism autonomously function thyroid nodule confirm T3 , T4 , and/or thyroidstimulating hormone . The subject severe liver hematologic disease ( sickle cell disease multiple myeloma ) , immunodeficiency . The subject take metformin ( e.g. , GlucophageÂ® ) therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Use Abdominal</keyword>
	<keyword>Contrast Enhanced</keyword>
	<keyword>Computed Tomography</keyword>
	<keyword>Optimize concentration</keyword>
	<keyword>dosage Ioforminol Injection</keyword>
</DOC>